Search

Author/Creator Kaye, Stan

3. Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer. Issue 4 (1st April 2011)

Authors:
Ledermann, Jonathan A.; Marth, Christian; Carey, Mark S.; Birrer, Michael; Bowtell, David D.L.; Kaye, Stan; McNeish, Iain; Oza, Amit; Scambia, Giovanni; Rustin, Gordon; Stehman, Frederick B.; Gershenson, David; Thomas, Gillian; Berns, Els; Casado, Antonio; Ottevanger, Nelleke; Hilpert, Felix; Kim...
Journal:
International journal of gynecological cancer
Issue:
Volume 21:Issue 4(2011)
Page Start:
763
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A study of motivations and expectations of patients seen in phase 1 oncology clinics. Issue 22 (26th September 2016)

Authors:
Dolly, Saoirse O.; Kalaitzaki, Eleftheria; Puglisi, Martina; Stimpson, Sarah; Hanwell, Janet; Fandos, Sonia Serrano; Stapleton, Sarah; Ansari, Thushara; Peckitt, Clare; Kaye, Stan; Lopez, Juanita; Yap, Timothy A.; van der Graaf, Winette; de Bono, Johann; Banerji, Udai
Journal:
Cancer
Issue:
Volume 122:Issue 22(2016)
Page Start:
3501
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037). (December 2020)

Authors:
Banerjee, Susana; Tovey, Holly; Bowen, Rebecca; Folkerd, Elizabeth; Kilburn, Lucy; McLachlan, Jennifer; Hall, Marcia; Tunariu, Nina; Attygalle, Ayoma; Lima, Joao Paulo Da Silveira Nogueira; Perry, Sophie; Chatfield, Peter; Hills, Margaret; Kaye, Stan; Attard, Gert; Dowsett, Mitch; Bliss, Judith M.
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors. (January 2018)

Authors:
Ameratunga, Malaka; Chénard-Poirier, Maxime; Moreno Candilejo, Irene; Pedregal, Manuel; Lui, Andrew; Dolling, David; Aversa, Caterina; Ingles Garces, Alvaro; Ang, Joo Ern; Banerji, Udai; Kaye, Stan; Gan, Hui; Doger, Bernard; Moreno, Victor; de Bono, Johann; Lopez, Juanita
Journal:
European journal of cancer
Issue:
Volume 89(2018)
Page Start:
56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor. Issue 3 (25th January 2013)

Authors:
Barber, Louise J; Sandhu, Shahneen; Chen, Lina; Campbell, James; Kozarewa, Iwanka; Fenwick, Kerry; Assiotis, Ioannis; Rodrigues, Daniel Nava; Filho, Jorge S Reis; Moreno, Victor; Mateo, Joaquin; Molife, L Rhoda; De Bono, Johann; Kaye, Stan; Lord, Christopher J; Ashworth, Alan
Journal:
Journal of pathology
Issue:
Volume 229:Issue 3(2013)
Page Start:
422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗